Narmada Gelatines Ltd
₹ 356
2.11%
14 Jan
- close price
About
Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]
Key Points
- Market Cap ₹ 215 Cr.
- Current Price ₹ 356
- High / Low ₹ 449 / 320
- Stock P/E 13.8
- Book Value ₹ 183
- Dividend Yield 2.81 %
- ROCE 20.0 %
- ROE 14.7 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 161%
Cons
- The company has delivered a poor sales growth of 7.66% over past five years.
- Company has a low return on equity of 11.0% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122 | 130 | 134 | 131 | 113 | 118 | 126 | 134 | 135 | 157 | 191 | 182 | 188 | |
100 | 106 | 113 | 120 | 109 | 112 | 116 | 120 | 127 | 143 | 171 | 161 | 165 | |
Operating Profit | 22 | 24 | 21 | 11 | 4 | 5 | 9 | 14 | 8 | 15 | 20 | 21 | 23 |
OPM % | 18% | 19% | 16% | 8% | 3% | 5% | 7% | 11% | 6% | 9% | 10% | 12% | 12% |
2 | 3 | 4 | 3 | 6 | 4 | 5 | 6 | 6 | 3 | 2 | 2 | 2 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 |
Profit before tax | 22 | 25 | 23 | 13 | 8 | 8 | 13 | 18 | 11 | 15 | 20 | 21 | 22 |
Tax % | 29% | 35% | 34% | 36% | 27% | 5% | 24% | 28% | 26% | 20% | 23% | 26% | |
15 | 16 | 16 | 8 | 6 | 8 | 10 | 13 | 8 | 12 | 15 | 15 | 16 | |
EPS in Rs | 25.67 | 27.10 | 25.62 | 13.70 | 10.10 | 13.29 | 16.63 | 21.29 | 13.98 | 20.40 | 25.26 | 25.34 | 25.71 |
Dividend Payout % | 13% | 12% | 14% | 29% | 40% | 30% | 60% | 47% | 72% | 49% | 396% | 39% |
Compounded Sales Growth | |
---|---|
10 Years: | 3% |
5 Years: | 8% |
3 Years: | 10% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 17% |
3 Years: | 39% |
TTM: | -10% |
Stock Price CAGR | |
---|---|
10 Years: | 7% |
5 Years: | 14% |
3 Years: | 23% |
1 Year: | -17% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 9% |
3 Years: | 11% |
Last Year: | 15% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4 | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 74 | 88 | 98 | 103 | 112 | 118 | 125 | 130 | 133 | 139 | 88 | 103 | 105 |
0 | 2 | 1 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 21 | |
14 | 16 | 15 | 17 | 21 | 16 | 22 | 24 | 26 | 25 | 23 | 25 | 22 | |
Total Liabilities | 92 | 109 | 120 | 128 | 140 | 140 | 155 | 161 | 165 | 170 | 117 | 134 | 155 |
25 | 24 | 23 | 23 | 22 | 25 | 24 | 26 | 29 | 27 | 28 | 27 | 29 | |
CWIP | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 3 |
Investments | 13 | 25 | 27 | 34 | 45 | 53 | 68 | 65 | 50 | 48 | 4 | 10 | 10 |
54 | 61 | 70 | 72 | 73 | 62 | 61 | 69 | 85 | 94 | 85 | 97 | 113 | |
Total Assets | 92 | 109 | 120 | 128 | 140 | 140 | 155 | 161 | 165 | 170 | 117 | 134 | 155 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 10 | 6 | 7 | 7 | 9 | 12 | 5 | 3 | 2 | 14 | 15 | |
-10 | -10 | -0 | -7 | -2 | -2 | -5 | -4 | 6 | 10 | 44 | -12 | |
-4 | -1 | -3 | -2 | -5 | -3 | -1 | -9 | -7 | -6 | -67 | -0 | |
Net Cash Flow | 1 | -1 | 3 | -2 | 0 | 4 | 6 | -8 | 2 | 6 | -9 | 2 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 38 | 40 | 41 | 47 | 52 | 59 | 56 | 55 | 48 | 36 | 37 | 44 |
Inventory Days | 157 | 174 | 194 | 169 | 192 | 144 | 144 | 166 | 166 | 185 | 152 | 161 |
Days Payable | 33 | 33 | 21 | 23 | 52 | 40 | 62 | 63 | 62 | 57 | 42 | 50 |
Cash Conversion Cycle | 162 | 182 | 214 | 193 | 193 | 163 | 138 | 158 | 152 | 164 | 147 | 155 |
Working Capital Days | 89 | 102 | 120 | 124 | 146 | 127 | 101 | 109 | 115 | 119 | 97 | 103 |
ROCE % | 29% | 28% | 21% | 12% | 4% | 5% | 7% | 11% | 5% | 10% | 16% | 20% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
8 Jan - Resignation of CFO Mahesh Verma effective January 7, 2025.
- Closure of Trading Window 30 Dec
-
Board Meeting Outcome for Revised Outcome
19 Dec - Approval of Q1 financial results and new Company Secretary.
-
Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.
5 Dec 2024 - Board approved investment in INDIA GELATINE & CHEMICALS LTD.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 8 Nov 2024
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company is engaged in the manufacture
of ossein and gelatin. It is located at Jabalpur
and has access to its main and essential
inputs of crushed bones, acid, lime and
water